Search Results 1161-1170 of 17869 for monoclonal antibody

  1. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

    ... monoclonal antibody (mAb) and for which no other more appropriate treatment option exists; At least one bidimensionally measurable lesion; Agreement to remain ...

  2. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  3. A Study To Investigate The Efficacy And Safety Of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib In Adults With Relapsed/Refractory Mantle Cell Lymphoma - Mayo Clinic

    Received 1 to 5 prior lines of systemic therapy including an anti-CD20 monoclonal antibody (mAb)-based immunotherapy or chemoimmunotherapy and requiring ...

  4. Therapeutic Drug Monitoring of Pembrolizumab and Nivolumab to Determine Dosages for Cancer Treatment - Mayo Clinic

    Adults who are just initiating monoclonal antibody therapy with pembrolizumab or nivolumab for melanoma or non-small cell lung cancer. Exclusion Criteria ...

  5. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

    Prior treatment with a monoclonal antibody within 4 weeks prior to ... Known or suspected hypersensitivity to monoclonal antibodies; Currently ...

  6. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  7. Publications - Pierre Noel, M.D. - Mayo Clinic

    Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood. 2004 Apr 15 ...

  8. A Study to Determine Number of Rounds of Plasma Exchange Needed to Decrease Measles Virus Antibodies for Measles Virus Cancer Therapy - Mayo Clinic

    A Study to Determine Number of Rounds of Plasma Exchange Needed to Decrease Measles Virus Antibodies for Measles Virus Cancer Therapy · More about research at ...

  9. MMRC Horizon One Adaptive Platform Trial Evaluating Therapies In RRMM - Mayo Clinic

    * An anti-CD38-monoclonal antibody * Must have received between 1-4 lines of prior systemic therapy * Prior BCMA-directed antibody-drug conjugate (ADC) or ...

  10. High blood protein Causes - Mayo Clinic

    https://www.niddk.nih.gov/health-information/kidney-disease/amyloidosis. Accessed Sept. 16, 2024. Monoclonal gammopathy of undetermined significance (MGUS).